dr. weber on the future of checkpoint inhibitors in melanoma
Published 4 years ago • 138 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:58
dr. weber on duration of checkpoint inhibitor therapy in melanoma
-
1:54
jeffrey weber, md, phd, discusses the efficacy of checkpoint inhibitors and immunotherapy
-
2:25
dr. weber on discontinuing immunotherapy in melanoma
-
3:10
targeted therapy or checkpoint inhibitors in melanoma: which is better?
-
7:44
melanoma: considerations in checkpoint inhibition
-
1:03
dr. weber on risk and benefits with immunotherapy combos in melanoma
-
2:28
future directions for research in non-melanoma skin cancer
-
3:43
metastatic melanoma: aislinn's story
-
56:25
dr. mark m. davis: enabling human immunology
-
7:51
checkpoint inhibitors: combination therapy in melanoma
-
5:26
checkpoint inhibitor therapy for treating melanoma
-
1:46
dr. long on the results of the pooled analysis of the combi-i trial in melanoma
-
1:06
dr. luke on the future role of immunotherapy combinations in melanoma
-
1:29
dr. weber on future treatment approaches for patients with melanoma
-
29:54
the future of melanoma treatment: moffitt's latest research
-
0:49
dr. weber on emerging therapies in melanoma
-
8:49
sequencing of checkpoint agents in melanoma
-
1:51
jeffrey weber explains organ-specific side effects of checkpoint inhibitors
-
7:38
how are you using pd-1 testing in melanoma?
-
2:06
dr. weber on next steps with pembrolizumab as melanoma treatment
-
1:16
dr. weber on emerging immunotherapy combinations in melanoma